Skip to main content
. 2021 Jun 9;10(2):1203–1214. doi: 10.1007/s40122-021-00273-w

Fig. 2.

Fig. 2

Comparison of duration (hours) and intensity of pain (NRS scores) at baseline (T0) and after six administrations of CGRP-mAbs (T1)